Aveanna Healthcare (AVAH) Stock Price, News & Analysis

Company Overview

Aveanna Healthcare, Inc. (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies. The company’s interdisciplinary care teams collaborate with families, physicians and payors to develop individualized care plans that address evolving patient needs. By combining clinical expertise with care coordination, Aveanna strives to improve patient outcomes and enhance quality of life for both children and adults requiring long-term or specialized in-home care.

Aveanna Healthcare maintains a network of more than 100 service locations across over 25 states, with a presence in major metropolitan and suburban markets throughout the Southeast, Northeast, Midwest and West. Its operational footprint includes established service lines in Texas, Florida, Pennsylvania, North Carolina, Massachusetts, Illinois and Georgia, among others. The company’s head office is based in Houston, Texas, serving as the hub for corporate leadership, strategic development and clinical quality oversight.

Founded in 2017 through the consolidation of regional home health and pediatric care providers, Aveanna has grown both organically and through targeted acquisitions aimed at expanding its geographic reach and service capabilities. The company is led by President and Chief Executive Officer William F. Allen, whose background in health care operations and private-equity-backed services has guided Aveanna’s focus on scaling integrated care solutions and fostering partnerships with hospitals, health systems and payors.

Key Stats

• Today's Range: $6.48 to $6.86
• 50-Day Range: $6.22 to $7.43
• 52-Week Range: $3.73 to $10.32
• Volume: 979,817 shs
• Average Volume: 1.20 million shs
• Market Capitalization: $1.49 billion
• P/E Ratio: 6.70
• Dividend Yield: N/A
• Price Target: $10.25
• Consensus Rating: Moderate Buy

Aveanna Healthcare Stock Analysis - MarketRank™

Aveanna Healthcare scored higher than 90% of companies evaluated by MarketBeat, and ranked 38th out of 856 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Aveanna Healthcare has received a consensus rating of Moderate Buy. The company's average rating score is 2.55, and is based on 1 strong buy rating, 4 buy ratings, 6 hold ratings, and no sell ratings.

Upside Potential

Aveanna Healthcare has a consensus price target of $10.25, representing about 56.7% upside from its current price of $6.54.

Amount of Analyst Coverage

Aveanna Healthcare has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 14.29%

Earnings Growth

Earnings for Aveanna Healthcare are expected to grow by 14.29% in the coming year, from $0.56 to $0.64 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Aveanna Healthcare is 6.38, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.31.

Price to Earnings Ratio vs. Sector

The P/E ratio of Aveanna Healthcare is 6.38, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 29.11.

Price to Book Value per Share Ratio

Aveanna Healthcare has a P/B Ratio of 7.03. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.85% of the float of Aveanna Healthcare has been sold short.

Short Interest Ratio / Days to Cover

Aveanna Healthcare has a short interest ratio ("days to cover") of 3.48, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Aveanna Healthcare has recently decreased by 11.03%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Aveanna Healthcare does not currently pay a dividend.

Dividend Growth

Aveanna Healthcare does not have a long track record of dividend growth.

News and Social Media

• Score: 1.3 / 5
• News Sentiment: N/A

Search Interest

3 people have searched for AVAH on MarketBeat in the last 30 days.

MarketBeat Follows

2 people have added Aveanna Healthcare to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.

Company Ownership

• Score: 1.6 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Aveanna Healthcare insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $5,458,175.00 in company stock.

Percentage Held by Insiders

5.30% of the stock of Aveanna Healthcare is held by insiders.

Percentage Held by Institutions

87.96% of the stock of Aveanna Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

AVAH Stock Analysis - Frequently Asked Questions

How have AVAH shares performed this year?

Aveanna Healthcare's stock was trading at $8.17 at the beginning of 2026. Since then, AVAH shares have decreased by 20.0% and is now trading at $6.54.

How were Aveanna Healthcare's earnings last quarter?

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) posted its earnings results on Thursday, November, 6th. The company reported $0.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.07 by $0.08. The business earned $621.94 million during the quarter, compared to analysts' expectations of $578.57 million. Aveanna Healthcare had a trailing twelve-month return on equity of 481.69% and a net margin of 9.25%.
Read the conference call transcript.

When did Aveanna Healthcare IPO?

Aveanna Healthcare (AVAH) raised $478 million in an IPO on Thursday, April 29th 2021. The company issued 38,200,000 shares at a price of $12.00-$13.00 per share. Barclays, J.P. Morgan, BMO Capital Markets and Credit Suisse served as the underwriters for the IPO and BofA Securities, Deutsche Bank Securities, Jefferies, RBC Capital Markets, Truist Securities, Raymond James, Stephens Inc., Drexel Hamilton and Siebert Williams Shank were co-managers.

Who are Aveanna Healthcare's major shareholders?

Aveanna Healthcare's top institutional shareholders include Emerald Advisers LLC (0.78%), Emerald Mutual Fund Advisers Trust (0.45%), Assenagon Asset Management S.A. (0.44%) and Hillsdale Investment Management Inc. (0.43%). Insiders that own company stock include JH Whitney Equity Partners V, Jeff Shaner, Edwin C Reisz, Matthew Buckhalter, Robert M Williams Jr, Paul R Vigano, Patrick A Cunningham, Deborah Stewart and Victor F Ganzi.
View institutional ownership trends.

How do I buy shares of Aveanna Healthcare?

Shares of AVAH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Aveanna Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Aveanna Healthcare investors own include American Water Works (AWK), Waste Connections (WCN), The RMR Group (RMR), AUO (AUOTY), DiamondRock Hospitality (DRH), iShares Micro-Cap ETF (IWC) and Voyager Therapeutics (VYGR).

Company Calendar

• Last Earnings: 11/06/2025
• Today: 5/06/2026
• Next Earnings (Estimated): 5/14/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED - OUTP/HM CRE
• Sub-Industry: Healthcare
• Current Symbol: NASDAQ:AVAH
• CIK: 1832332
• Web: www.aveanna.com
• Phone: 770-441-1580
• Fax: N/A
• Employees: 35,500
• Year Founded: 2017

Price Target and Rating

• Average Price Target for Aveanna Healthcare: $10.25
• High Price Target: $13.00
• Low Price Target: $8.00
• Potential Upside/Downside: +50.2%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.55
• Research Coverage: 11 Analysts

Profitability

• EPS (Trailing Twelve Months): $1.02
• Trailing P/E Ratio: 6.68
• Forward P/E Ratio: 12.19
• P/E Growth: N/A
• Net Income: $225.03 million
• Net Margins: 9.25%
• Pretax Margin: 4.40%
• Return on Equity: 481.69%
• Return on Assets: 6.08%

Debt

• Debt-to-Equity Ratio: 6.62
• Current Ratio: 1.32
• Quick Ratio: 1.32

Sales & Book Value

• Annual Sales: $2.43 billion
• Price / Sales: 0.61
• Cash Flow: $0.71 per share
• Price / Cash Flow: 9.61
• Book Value: $0.93 per share
• Price / Book: 7.34

Miscellaneous

• Outstanding Shares: 217,510,000
• Free Float: 205,982,000
• Market Cap: $1.48 billion
• Optionable: Optionable
• Beta: 1.93